Lonza | LONN - Cost Of Sales


Lonza reported CHF2.28B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.5B 95M Jun/2026
Alcon AG USD 1.18B 26M Mar/2026
Almirall EUR 199.26M 7.76M Jun/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
BASF EUR 12.87B 1.01B Jun/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Demant DKK 2.89B 188M Dec/2025
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Geberit CHF 229.8M 22.8M Dec/2025
Genmab DKK 84M 19M Jun/2026
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Johnson Matthey GBP 6.9B 1.86B Jun/2026
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.71B 251M Jun/2026
Philips EUR 2.21B 70M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
Sika AG CHF 2.77B 49.8M Dec/2025
Smith & Nephew USD 901M 31M Jun/2026
Solvay EUR 928M 52M Jun/2026
UCB EUR 1.07B 146M Dec/2025